Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 19 studies | 47% ± 16% | |
conventional dendritic cell | 13 studies | 37% ± 14% | |
endothelial cell | 11 studies | 49% ± 27% | |
dendritic cell | 7 studies | 32% ± 14% | |
macrophage | 6 studies | 45% ± 22% | |
endothelial cell of sinusoid | 5 studies | 61% ± 17% | |
vein endothelial cell | 5 studies | 24% ± 9% |
Insufficient scRNA-seq data for expression of DNASE1L3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2833.23 | 226 / 226 | 82% | 13.08 | 334 / 406 |
thymus | 100% | 1120.85 | 652 / 653 | 79% | 9.21 | 479 / 605 |
kidney | 100% | 2014.04 | 89 / 89 | 70% | 6.12 | 630 / 901 |
adrenal gland | 100% | 2302.85 | 258 / 258 | 69% | 10.33 | 159 / 230 |
lung | 90% | 706.07 | 520 / 578 | 45% | 2.92 | 525 / 1155 |
breast | 94% | 633.59 | 433 / 459 | 22% | 1.02 | 251 / 1118 |
spleen | 100% | 8937.49 | 241 / 241 | 0% | 0 | 0 / 0 |
esophagus | 43% | 300.73 | 624 / 1445 | 50% | 4.53 | 91 / 183 |
intestine | 48% | 456.61 | 460 / 966 | 42% | 2.89 | 223 / 527 |
adipose | 89% | 405.91 | 1069 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 20.13 | 25 / 29 |
skin | 63% | 157.13 | 1131 / 1809 | 24% | 2.90 | 111 / 472 |
eye | 0% | 0 | 0 / 0 | 83% | 6.80 | 66 / 80 |
tonsil | 0% | 0 | 0 / 0 | 80% | 9.96 | 36 / 45 |
bladder | 52% | 125.95 | 11 / 21 | 27% | 3.23 | 134 / 504 |
uterus | 36% | 97.01 | 62 / 170 | 32% | 4.78 | 147 / 459 |
heart | 59% | 348.86 | 505 / 861 | 0% | 0 | 0 / 0 |
prostate | 31% | 86.74 | 75 / 245 | 24% | 0.79 | 118 / 502 |
blood vessel | 51% | 194.52 | 679 / 1335 | 0% | 0 | 0 / 0 |
stomach | 13% | 27.45 | 48 / 359 | 37% | 2.29 | 105 / 286 |
pancreas | 3% | 5.96 | 11 / 328 | 25% | 1.44 | 45 / 178 |
peripheral blood | 25% | 209.28 | 234 / 929 | 0% | 0 | 0 / 0 |
ovary | 16% | 40.26 | 28 / 180 | 0% | 0.01 | 1 / 430 |
brain | 0% | 1.27 | 12 / 2642 | 4% | 0.39 | 29 / 705 |
muscle | 1% | 2.94 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070948 | Biological process | regulation of neutrophil mediated cytotoxicity |
GO_0010623 | Biological process | programmed cell death involved in cell development |
GO_0006309 | Biological process | apoptotic DNA fragmentation |
GO_0002673 | Biological process | regulation of acute inflammatory response |
GO_0006259 | Biological process | DNA metabolic process |
GO_0002283 | Biological process | neutrophil activation involved in immune response |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0004536 | Molecular function | DNA nuclease activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0004530 | Molecular function | deoxyribonuclease I activity |
Gene name | DNASE1L3 |
Protein name | Deoxyribonuclease 1 like 3 Deoxyribonuclease gamma (DNase gamma) (EC 3.1.21.-) (DNase I homolog protein DHP2) (Deoxyribonuclease I-like 3) (DNase I-like 3) (Liver and spleen DNase) (LS-DNase) (LSD) Deoxyribonuclease |
Synonyms | DNAS1L3 DHP2 |
Description | FUNCTION: Has DNA hydrolytic activity. Is capable of both single- and double-stranded DNA cleavage, producing DNA fragments with 3'-OH ends (By similarity). Can cleave chromatin to nucleosomal units and cleaves nucleosomal and liposome-coated DNA . Acts in internucleosomal DNA fragmentation (INDF) during apoptosis and necrosis . The role in apoptosis includes myogenic and neuronal differentiation, and BCR-mediated clonal deletion of self-reactive B cells (By similarity). Is active on chromatin in apoptotic cell-derived membrane-coated microparticles and thus suppresses anti-DNA autoimmunity . Together with DNASE1, plays a key role in degrading neutrophil extracellular traps (NETs) (By similarity). NETs are mainly composed of DNA fibers and are released by neutrophils to bind pathogens during inflammation (By similarity). Degradation of intravascular NETs by DNASE1 and DNASE1L3 is required to prevent formation of clots that obstruct blood vessels and cause organ damage following inflammation (By similarity). . |
Accessions | ENST00000461914.7 C9J0L2 Q13609 C9J9N0 ENST00000483681.5 ENST00000460422.1 ENST00000477209.5 ENST00000486455.5 [Q13609-2] H7C4R7 A0A0A0MT68 ENST00000394549.7 [Q13609-1] |